CytomX Therapeutics (CTMX) Change in Cash (2014 - 2026)
CytomX Therapeutics (CTMX) posted Change in Cash of $16.2 million for Q1 2026, up 176.89% on a QoQ basis from -$21.0 million in Q4 2025, and up 69.17% year-over-year from $9.6 million in Q1 2025.
CytomX Therapeutics (CTMX) Change in Cash (2014 - 2026) Analysis & Trends
CytomX Therapeutics' Change in Cash history runs 13 years deep, the most recent figure standing at $16.2 million for Q1 2026.
- Quarterly Change in Cash rose 69.17% year-over-year to $16.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.3 million (down 258.52% YoY) and the FY2025 annual result came in at -$24.9 million, down 218.55% from the prior year.
- Change in Cash was $16.2 million for Q1 2026 at CytomX Therapeutics, up from -$21.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $98.6 million in Q4 2022 and bottomed at -$137.3 million in Q1 2023.
- A 5-year average of -$10.4 million and a median of -$2.6 million in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash jumped 498.98% — and 2025, when it sank 732.77%.
- CytomX Therapeutics' Change in Cash stood at $98.6 million in 2022, then tumbled by 108.98% to -$8.9 million in 2023, then surged by 71.49% to -$2.5 million in 2024, then sank by 732.77% to -$21.0 million in 2025, then jumped by 176.89% to $16.2 million in 2026.
- Business Quant data shows CTMX's Change in Cash at $16.2 million in Q1 2026, -$21.0 million in Q4 2025, and -$14.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - | 16.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.16 Mn |
| Dec 31, 2025 | -21.02 Mn |
| Sep 30, 2025 | -14.86 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 9.55 Mn |
| Dec 31, 2024 | -2.52 Mn |
| Sep 30, 2024 | -2.56 Mn |
| Jun 30, 2024 | 7.06 Mn |
| Mar 31, 2024 | 19.01 Mn |
| Dec 31, 2023 | -8.85 Mn |
| Sep 30, 2023 | -31.51 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | -137.29 Mn |
| Dec 31, 2022 | 98.62 Mn |
| Sep 30, 2022 | -34.26 Mn |
| Jun 30, 2022 | -34.20 Mn |
| Mar 31, 2022 | -42.04 Mn |
| Dec 31, 2021 | -30.75 Mn |
| Sep 30, 2021 | -19.86 Mn |
| Jun 30, 2021 | -73.52 Mn |